CY1995A - Use of 2-amino-2,4,4-trimethylpentane salt of clavulanic acid in producing pharmaceutically acceptable salts of clavulanic acid - Google Patents

Use of 2-amino-2,4,4-trimethylpentane salt of clavulanic acid in producing pharmaceutically acceptable salts of clavulanic acid Download PDF

Info

Publication number: CY1995A
Authority: CY; Cyprus
Prior art keywords: clavulanic acid; salt; amino; pharmaceutically acceptable; trimethylpentane
Prior art date: 1992-03-10

Application number

CY199597A

Other languages

English (en)

Original Assignee

Biochemie Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-03-10

Filing date

1997-09-05

Publication date

1997-09-05

1997-09-05 Application filed by Biochemie Gmbh filed Critical Biochemie Gmbh

1997-09-05 Publication of CY1995A publication Critical patent/CY1995A/en

Links

HZZVJAQRINQKSD-PBFISZAISA-N clavulanic acid Chemical compound OC(=O)[C@H]1C(=C/CO)/O[C@@H]2CC(=O)N21 HZZVJAQRINQKSD-PBFISZAISA-N 0.000 title claims description 72
HZZVJAQRINQKSD-UHFFFAOYSA-N Clavulanic acid Natural products OC(=O)C1C(=CCO)OC2CC(=O)N21 HZZVJAQRINQKSD-UHFFFAOYSA-N 0.000 title claims description 71
229960003324 clavulanic acid Drugs 0.000 title claims description 71
150000003839 salts Chemical class 0.000 title claims description 31
QIJIUJYANDSEKG-UHFFFAOYSA-N 2,4,4-trimethylpentan-2-amine Chemical class CC(C)(C)CC(C)(C)N QIJIUJYANDSEKG-UHFFFAOYSA-N 0.000 title claims description 29
XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 27
238000000034 method Methods 0.000 claims description 15
239000003960 organic solvent Substances 0.000 claims description 10
LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 8
238000000605 extraction Methods 0.000 claims description 8
238000004519 manufacturing process Methods 0.000 claims description 8
NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 claims description 6
UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 claims description 6
DKPFZGUDAPQIHT-UHFFFAOYSA-N butyl acetate Chemical compound CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 claims description 6
238000000855 fermentation Methods 0.000 claims description 6
230000004151 fermentation Effects 0.000 claims description 6
FDPIMTJIUBPUKL-UHFFFAOYSA-N pentan-3-one Chemical group CCC(=O)CC FDPIMTJIUBPUKL-UHFFFAOYSA-N 0.000 claims description 6
239000000706 filtrate Substances 0.000 claims description 5
JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 claims description 4
XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 claims description 4
HPXRVTGHNJAIIH-UHFFFAOYSA-N cyclohexanol Chemical compound OC1CCCCC1 HPXRVTGHNJAIIH-UHFFFAOYSA-N 0.000 claims description 2
-1 amine salts Chemical class 0.000 description 19
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 18
KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 12
239000000243 solution Substances 0.000 description 12
239000002904 solvent Substances 0.000 description 10
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
239000000203 mixture Substances 0.000 description 7
229910052784 alkaline earth metal Inorganic materials 0.000 description 6
150000001447 alkali salts Chemical class 0.000 description 5
WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
238000002955 isolation Methods 0.000 description 4
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
239000003513 alkali Substances 0.000 description 3
238000001035 drying Methods 0.000 description 3
238000000746 purification Methods 0.000 description 3
239000011734 sodium Substances 0.000 description 3
229910052708 sodium Inorganic materials 0.000 description 3
OBETXYAYXDNJHR-UHFFFAOYSA-N 2-Ethylhexanoic acid Chemical compound CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 2
241000894006 Bacteria Species 0.000 description 2
229930186147 Cephalosporin Natural products 0.000 description 2
CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
229930182555 Penicillin Natural products 0.000 description 2
150000001412 amines Chemical class 0.000 description 2
239000002585 base Substances 0.000 description 2
229940124587 cephalosporin Drugs 0.000 description 2
150000001780 cephalosporins Chemical class 0.000 description 2
238000006243 chemical reaction Methods 0.000 description 2
238000002425 crystallisation Methods 0.000 description 2
238000001914 filtration Methods 0.000 description 2
150000002960 penicillins Chemical class 0.000 description 2
239000011591 potassium Substances 0.000 description 2
229910052700 potassium Inorganic materials 0.000 description 2
ZUFQCVZBBNZMKD-UHFFFAOYSA-M potassium 2-ethylhexanoate Chemical compound [K+].CCCCC(CC)C([O-])=O ZUFQCVZBBNZMKD-UHFFFAOYSA-M 0.000 description 2
238000001556 precipitation Methods 0.000 description 2
238000011084 recovery Methods 0.000 description 2
238000001953 recrystallisation Methods 0.000 description 2
238000003756 stirring Methods 0.000 description 2
YBRBMKDOPFTVDT-UHFFFAOYSA-N tert-butylamine Chemical class CC(C)(C)N YBRBMKDOPFTVDT-UHFFFAOYSA-N 0.000 description 2
YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
OBETXYAYXDNJHR-SSDOTTSWSA-M (2r)-2-ethylhexanoate Chemical class CCCC[C@@H](CC)C([O-])=O OBETXYAYXDNJHR-SSDOTTSWSA-M 0.000 description 1
QJVHTELASVOWBE-AGNWQMPPSA-N (2s,5r,6r)-6-[[(2r)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid;(2r,3z,5r)-3-(2-hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptane-2-carboxylic acid Chemical compound OC(=O)[C@H]1C(=C/CO)/O[C@@H]2CC(=O)N21.C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 QJVHTELASVOWBE-AGNWQMPPSA-N 0.000 description 1
FLTJDUOFAQWHDF-UHFFFAOYSA-N 2,2-dimethylhexane Chemical class CCCCC(C)(C)C FLTJDUOFAQWHDF-UHFFFAOYSA-N 0.000 description 1
QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
208000035473 Communicable disease Diseases 0.000 description 1
102000004190 Enzymes Human genes 0.000 description 1
108090000790 Enzymes Proteins 0.000 description 1
FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 1
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
241000187433 Streptomyces clavuligerus Species 0.000 description 1
239000002253 acid Substances 0.000 description 1
239000011149 active material Substances 0.000 description 1
239000000654 additive Substances 0.000 description 1
230000000996 additive effect Effects 0.000 description 1
230000000844 anti-bacterial effect Effects 0.000 description 1
239000007864 aqueous solution Substances 0.000 description 1
239000003782 beta lactam antibiotic agent Substances 0.000 description 1
230000003115 biocidal effect Effects 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
229910052791 calcium Inorganic materials 0.000 description 1
239000011575 calcium Substances 0.000 description 1
SHZIWNPUGXLXDT-UHFFFAOYSA-N caproic acid ethyl ester Natural products CCCCCC(=O)OCC SHZIWNPUGXLXDT-UHFFFAOYSA-N 0.000 description 1
125000004432 carbon atom Chemical group C* 0.000 description 1
150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
150000001734 carboxylic acid salts Chemical class 0.000 description 1
238000004587 chromatography analysis Methods 0.000 description 1
239000012024 dehydrating agents‎ Substances 0.000 description 1
150000002148 esters Chemical class 0.000 description 1
238000009472 formulation Methods 0.000 description 1
238000005227 gel permeation chromatography Methods 0.000 description 1
230000002401 inhibitory effect Effects 0.000 description 1
239000013067 intermediate product Substances 0.000 description 1
239000003456 ion exchange resin Substances 0.000 description 1
229920003303 ion-exchange polymer Polymers 0.000 description 1
150000002576 ketones Chemical class 0.000 description 1
229910052749 magnesium Inorganic materials 0.000 description 1
239000011777 magnesium Substances 0.000 description 1
229910052943 magnesium sulfate Inorganic materials 0.000 description 1
235000019341 magnesium sulphate Nutrition 0.000 description 1
239000012044 organic layer Substances 0.000 description 1
239000003791 organic solvent mixture Substances 0.000 description 1
239000008194 pharmaceutical composition Substances 0.000 description 1
ABVRVIZBZKUTMK-JSYANWSFSA-M potassium clavulanate Chemical compound [K+].[O-]C(=O)[C@H]1C(=C/CO)/O[C@@H]2CC(=O)N21 ABVRVIZBZKUTMK-JSYANWSFSA-M 0.000 description 1
159000000001 potassium salts Chemical class 0.000 description 1
239000002244 precipitate Substances 0.000 description 1
238000002360 preparation method Methods 0.000 description 1
239000000047 product Substances 0.000 description 1
239000011541 reaction mixture Substances 0.000 description 1
238000004064 recycling Methods 0.000 description 1
BHRZNVHARXXAHW-UHFFFAOYSA-N sec-butylamine Chemical compound CCC(C)N BHRZNVHARXXAHW-UHFFFAOYSA-N 0.000 description 1
239000007787 solid Substances 0.000 description 1
239000012453 solvate Substances 0.000 description 1
239000011877 solvent mixture Substances 0.000 description 1
238000005292 vacuum distillation Methods 0.000 description 1
238000005406 washing Methods 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D503/00—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Oncology (AREA)
Pharmacology & Pharmacy (AREA)
Communicable Diseases (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Cephalosporin Compounds (AREA)

CY199597A 1992-03-10 1997-09-05 Use of 2-amino-2,4,4-trimethylpentane salt of clavulanic acid in producing pharmaceutically acceptable salts of clavulanic acid CY1995A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
AT0047292A AT400033B (de)	1992-03-10	1992-03-10	Neues verfahren zur isolierung und reinigung von clavulansäure und zur herstellung von pharmakologisch verträglichen salzen derselben

Publications (1)

Publication Number	Publication Date
CY1995A true CY1995A (en)	1997-09-05

Family

ID=3491521

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CY199597A CY1995A (en)	1992-03-10	1997-09-05	Use of 2-amino-2,4,4-trimethylpentane salt of clavulanic acid in producing pharmaceutically acceptable salts of clavulanic acid

Country Status (21)

Country	Link
US (4)	US20010036940A1 (de)
JP (2)	JP2817563B2 (de)
CN (3)	CN1045604C (de)
AT (1)	AT400033B (de)
AU (1)	AU659282B2 (de)
CH (1)	CH685054A5 (de)
CY (1)	CY1995A (de)
DE (1)	DE4307422B4 (de)
DK (1)	DK26093A (de)
ES (1)	ES2058029B1 (de)
FI (1)	FI101965B1 (de)
FR (1)	FR2688506B1 (de)
GB (1)	GB2264944B (de)
GR (1)	GR1002329B (de)
HK (1)	HK42696A (de)
IE (1)	IE70926B1 (de)
IT (1)	IT1261213B (de)
NL (1)	NL9300430A (de)
NO (1)	NO301372B1 (de)
SE (1)	SE508043C2 (de)
TW (1)	TW364907B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AT399155B (de) *	1992-03-26	1995-03-27	Lek Tovarna Farmacevtskih	Neue alkylendiammonium-diclavulanat-derivate, verfahren zu deren herstellung sowie deren verwendung
SI9300296B (sl) *	1992-06-11	1998-06-30	Smithkline Beecham P.L.C.	Postopek in intermedianti za pripravo klavulanske kisline
KR100200239B1 (ko) *	1992-10-21	1999-06-15	김충환	클라불란산 칼륨염의 제조방법
PT658558E (pt)	1993-11-17	2001-06-29	Biochemie Gmbh	Separacao de isomeros da cefalosporina
GB9426261D0 (en)	1994-12-24	1995-02-22	Spurcourt Ltd	Clavulanic acid salts
MD1744F2 (ro) *	1995-02-25	2001-09-30	Spurcourt Limited	Săruri ale acidului clavulanic şi procedeu de obţinere a lor
KR100200242B1 (ko) *	1995-05-16	1999-06-15	김충환	클라불란산염의 제조 방법
AT403375B (de) *	1995-11-15	1998-01-26	Biochemie Gmbh	Verfahren zur fällung von alkalisalzen der clavulansäure
TR200100082T2 (tr) *	1998-07-16	2001-06-21	Dsm N.V.	Klavulanik asit tuz ve esterlerinin hazırlanması için geliştirilmiş yöntem
US6979735B1 (en) *	1999-04-01	2005-12-27	Dsm N.V.	Agglomerates by crystallization
AU776184B2 (en) *	2000-05-13	2004-09-02	Smithkline Beecham Plc	Process for the purification of a salt of clavulanic acid
EP1933857A2 (de) *	2005-09-07	2008-06-25	Jennerex Biotherapeutics ULC	Systemische behandlung von metastasierten und/oder systemisch dissemierten tumoren mit gm-csf-exprimierenden pockenviren
JP7028064B2 (ja)	2018-05-30	2022-03-02	横河電機株式会社	機器保全装置、機器保全方法、機器保全プログラム及び記録媒体
CN115768544A (zh)	2020-07-10	2023-03-07	碳清洁解决方案有限公司	用低品位热从溶剂去除二氧化碳的方法和系统

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3288800A (en)	1962-05-29	1966-11-29	Squibb & Sons Inc	Schiff's bases of 6-amino-penicillanic acid and purification of 6-aminopenicillanic acid by the use thereof
GB1508977A (en)	1974-04-20	1978-04-26	Beecham Group Ltd	Beta-lactam antibiotic from streptomyces clavuligerus
NZ177159A (en)	1974-04-20	1978-03-06	Beecham Group Ltd	Clavulanic acid, salts, esters and preparation thereof from streptomyces clavuligerus: pharmaceutical compositions
US4110165A (en)	1974-04-20	1978-08-29	Beecham Group Limited	Process for the production of clavulanic acid
GB1543563A (en)	1975-02-07	1979-04-04	Glaxo Lab Ltd	Beta-lactam antibiotic in purified form
US4144242A (en)	1975-02-07	1979-03-13	Glaxo Laboratories Limited	Process for the purification of clavulanic acid
GB1561395A (en)	1976-02-26	1980-02-20	Beecham Group Ltd	-lactam antibiotic
GB1578739A (en) *	1976-07-23	1980-11-05	Beecham Group Ltd	Amine salts of clavulanic acid methods for their preparation and compositions containing them
GB2003863B (en)	1977-09-01	1982-03-31	Beecham Group Ltd	Chemical process
EP0002312B1 (de)	1977-11-26	1982-02-03	Beecham Group Plc	Clavulansäure-derivate sowie sie enthaltende pharmazeutische Zusammensetzungen
BE862211A (fr) *	1977-12-22	1978-06-22	Beecham Group Ltd	Agents antibacteriens
US4454069A (en)	1979-08-24	1984-06-12	Beecham Group Limited	Clavulanic acid salts and their preparation from the tertiary butyl amine salt
EP0026044B1 (de)	1979-08-24	1983-06-08	Beecham Group Plc	Aminsalz der Clavulansäure, seine Herstellung und Verwendung
NZ213963A (en)	1984-10-27	1989-01-06	Antibioticos Sa	Production of clavulanic acid
GB8618888D0 (en)	1986-08-01	1986-09-10	Davy Mckee Ltd	Process
DK175709B1 (da)	1987-01-29	2005-01-31	Beecham Group Plc	Fremgangsmåde til fremstilling af kalium-clavulanat
US5679789A (en)	1987-01-29	1997-10-21	Beecham Group, P.L.C.	Pharmaceutical compositions comprising potassium clavulanate and methods of using them
ES2010143A6 (es) *	1989-03-01	1989-10-16	Pharma Mar S A Pharmar	Un nuevo procedimiento de obtencion del acido z(2r,5r)-3-(2-hiadroxietiliden)-7- oxo-4-oxa-1-azabiciclo(3,2,0) -heptano-2-carboxilico y de sales estares farmaceutiacamente aceptables del mismo,a partir de caldos de fermentacion de streptomyces, sp.
US5210296A (en)	1990-11-19	1993-05-11	E. I. Du Pont De Nemours And Company	Recovery of lactate esters and lactic acid from fermentation broth
AT399155B (de)	1992-03-26	1995-03-27	Lek Tovarna Farmacevtskih	Neue alkylendiammonium-diclavulanat-derivate, verfahren zu deren herstellung sowie deren verwendung
SI9300296B (sl)	1992-06-11	1998-06-30	Smithkline Beecham P.L.C.	Postopek in intermedianti za pripravo klavulanske kisline
SI9200139A (en)	1992-07-08	1994-03-31	Lek Tovarna Farmacevtskih	New inclusion complex of clavulanic acid with hydrophylyc and hydropholyc beta-cyclodextrin derivates for production of them
KR100200239B1 (ko)	1992-10-21	1999-06-15	김충환	클라불란산 칼륨염의 제조방법
GB9401969D0 (en)	1994-02-02	1994-03-30	Smithkline Beecham Plc	Process
SI9400107A (en)	1994-03-02	1995-10-31	Lek Tovarna Farmacevtskih	New process of the isolation of clavulanic acid and its pharmaceutical salts from fermented broth of streptomyces sp.p 6621 ferm p 2804.
GB2298201B (en)	1995-02-25	1997-05-28	Spurcourt Ltd	Clavulanic acid salts
MD1744F2 (ro)	1995-02-25	2001-09-30	Spurcourt Limited	Săruri ale acidului clavulanic şi procedeu de obţinere a lor
SI9500074A (en)	1995-03-10	1996-10-31	Lek Tovarna Farmacevtskih	Process for preparation of alkani salts of clavulanic acid.
SI9500134B (sl)	1995-04-20	2004-04-30	Lek,	Postopek za pripravo čistih alkalijskih soli klavulanske kisline
KR100200242B1 (ko)	1995-05-16	1999-06-15	김충환	클라불란산염의 제조 방법
GB9515809D0 (en)	1995-08-02	1995-10-04	Smithkline Beecham Plc	Process
SI9500265A1 (en)	1995-08-28	1997-02-28	Lek Tovarna Farmacevtskih	Process for purification of the aqueous fermented broth filtrate of streptomyces sp. p 6621 ferm p 2804 by ultrafiltration
US6414142B1 (en)	1996-06-13	2002-07-02	Smithkline Beecham Corporation	Process for preparing potassium clavulanate
TR199901631T2 (xx)	1996-11-11	1999-09-21	Gist-Brocades B.V.	Klavülanik asitin esterleri ve tuzlarının hazırlanması için işlem.

1992
- 1992-03-10 AT AT0047292A patent/AT400033B/de not_active IP Right Cessation
1993
- 1993-03-05 CH CH670/93A patent/CH685054A5/de not_active IP Right Cessation
- 1993-03-08 NO NO930829A patent/NO301372B1/no unknown
- 1993-03-08 GB GB9304704A patent/GB2264944B/en not_active Expired - Fee Related
- 1993-03-08 SE SE9300758A patent/SE508043C2/sv not_active IP Right Cessation
- 1993-03-08 JP JP5046691A patent/JP2817563B2/ja not_active Expired - Fee Related
- 1993-03-09 FI FI931032A patent/FI101965B1/fi active
- 1993-03-09 CN CN93102897A patent/CN1045604C/zh not_active Expired - Fee Related
- 1993-03-09 AU AU34070/93A patent/AU659282B2/en not_active Ceased
- 1993-03-09 DE DE4307422A patent/DE4307422B4/de not_active Expired - Fee Related
- 1993-03-09 FR FR9302720A patent/FR2688506B1/fr not_active Expired - Fee Related
- 1993-03-09 DK DK026093A patent/DK26093A/da not_active Application Discontinuation
- 1993-03-09 GR GR930100090A patent/GR1002329B/el not_active IP Right Cessation
- 1993-03-09 IE IE930172A patent/IE70926B1/en not_active IP Right Cessation
- 1993-03-10 IT ITRM930147A patent/IT1261213B/it active IP Right Grant
- 1993-03-10 ES ES09300483A patent/ES2058029B1/es not_active Expired - Fee Related
- 1993-03-10 NL NL9300430A patent/NL9300430A/nl active Search and Examination
- 1993-05-04 TW TW082103491A patent/TW364907B/zh not_active IP Right Cessation
1996
- 1996-03-14 HK HK42696A patent/HK42696A/xx not_active IP Right Cessation
- 1996-06-29 CN CN96108276A patent/CN1145906A/zh active Pending
- 1996-06-29 CN CN96108278A patent/CN1150153A/zh active Pending
1997
- 1997-08-13 JP JP9218732A patent/JPH1067785A/ja active Pending
- 1997-09-05 CY CY199597A patent/CY1995A/en unknown
2001
- 2001-06-26 US US09/892,179 patent/US20010036940A1/en not_active Abandoned
2002
- 2002-02-08 US US10/071,364 patent/US20020072513A1/en not_active Abandoned
- 2002-09-20 US US10/251,948 patent/US20030022882A1/en not_active Abandoned
2003
- 2003-05-13 US US10/437,097 patent/USH2158H1/en not_active Abandoned

Also Published As

Publication number	Publication date
FI931032A0 (fi)	1993-03-09
GB2264944A (en)	1993-09-15
GB2264944B (en)	1995-09-06
SE508043C2 (sv)	1998-08-17
FI101965B (fi)	1998-09-30
JP2817563B2 (ja)	1998-10-30
ATA47292A (de)	1995-01-15
FR2688506B1 (fr)	1995-06-23
FR2688506A1 (fr)	1993-09-17
ES2058029A1 (es)	1994-10-16
HK42696A (en)	1996-03-22
GR930100090A (el)	1993-11-30
AU3407093A (en)	1993-09-16
NL9300430A (nl)	1993-10-01
DK26093A (da)	1993-09-11
SE9300758L (sv)	1993-09-11
CN1145906A (zh)	1997-03-26
CN1079743A (zh)	1993-12-22
DK26093D0 (da)	1993-03-09
CN1150153A (zh)	1997-05-21
NO301372B1 (no)	1997-10-20
CN1045604C (zh)	1999-10-13
JPH1067785A (ja)	1998-03-10
US20030203886A1 (en)	2003-10-30
DE4307422A1 (de)	1993-09-30
AU659282B2 (en)	1995-05-11
IE70926B1 (en)	1997-01-15
DE4307422B4 (de)	2004-11-25
NO930829D0 (no)	1993-03-08
JPH0641143A (ja)	1994-02-15
ITRM930147A0 (it)	1993-03-10
AT400033B (de)	1995-09-25
US20020072513A1 (en)	2002-06-13
ITRM930147A1 (it)	1994-09-10
USH2158H1 (en)	2006-06-06
IE930172A1 (en)	1993-09-22
CH685054A5 (de)	1995-03-15
FI101965B1 (fi)	1998-09-30
GR1002329B (el)	1996-05-15
US20030022882A1 (en)	2003-01-30
ES2058029B1 (es)	1995-05-01
FI931032L (fi)	1993-09-11
TW364907B (en)	1999-07-21
US20010036940A1 (en)	2001-11-01
IT1261213B (it)	1996-05-09
GB9304704D0 (en)	1993-04-28
SE9300758D0 (sv)	1993-03-08
NO930829L (no)	1993-09-13

Publication	Publication Date	Title
AU604553B2 (en)	1990-12-20	Azithromycin dihydrate
EP0672669B1 (de)	1997-09-10	Verfahren zur Herstellung von Kalium Clavulanat
USH2158H1 (en)	2006-06-06	Process for the production of clavulanic acid salts
HK1003245B (en)	1998-10-16	Process for the preparation of potassium clavulanate
US5310898A (en)	1994-05-10	Alkylenediammonium diclavulanate derivatives, a process for the preparation thereof as well as the use thereof
US4775750A (en)	1988-10-04	Process for preparing sodium cefuroxime
GB2145409A (en)	1985-03-27	Crystalline cefuroxime axetil
US4786742A (en)	1988-11-22	Crystalline lithium pseudomonete
EP0594099A1 (de)	1994-04-27	Verfahren zur Reinigung von roher Clavulansäure
JPH11501023A (ja)	1999-01-26	クラブラン酸塩
US3634417A (en)	1972-01-11	Purification of 7alpha-aminoarylacetamido delta**3-4-carboxy-cephalosporins
US3634416A (en)	1972-01-11	Purification of 7alpha-aminoarylacetamido delta**3-4-carboxy-cephalosporins
US4168375A (en)	1979-09-18	Process for the recovery of cephalosporin C and derivatives thereof
WO2004037832A1 (en)	2004-05-06	An improved process for the preparation of cefixime
CA2380183A1 (en)	2001-02-01	A process for the synthesis of beta-lactam derivatives
HU190017B (hu)	1986-08-28	Eljárás primicin elkülönítésére és tisztítására
IES65748B2 (en)	1995-11-01	Process for the separation of the optical antipodes of racemic phenyl-(2-Pyridyl)-dimethylpropylamines
KR19980035249A (ko)	1998-08-05	세팔로스포린 유도체의 에스테르 제조방법